Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
JAMA Neurology - United States
doi 10.1001/jamaneurol.2015.1867
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2015
Authors
Publisher
American Medical Association (AMA)